# A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis

> **NCT00726401** · PHASE2 · COMPLETED · sponsor: **Afexa Life Sciences Inc** · enrollment: 200 (estimated)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** COLD-fX
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00726401
- **Lead sponsor:** Afexa Life Sciences Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2010-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726401, "A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00726401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*